Predictive Technology Group, Inc. focuses on developing innovative healthcare solutions, particularly in the predictive analytics space for patient outcomes. The company operates primarily in the U.S. and leverages proprietary algorithms to enhance clinical decision-making, which sets it apart in a competitive biotechnology landscape.
The company generates revenue through a combination of predictive analytics services, software licensing, and consulting services aimed at healthcare providers. Its competitive advantage lies in its proprietary algorithms and data analytics capabilities that improve patient outcomes, which can lead to cost savings for healthcare systems.
Adoption rates of predictive analytics in healthcare settings
Partnerships with major healthcare providers
Regulatory approvals for new products
Changes in healthcare spending patterns
Technological disruption from competitors with advanced analytics capabilities
Regulatory changes affecting healthcare data usage
Emergence of new entrants in predictive analytics for healthcare
Established players enhancing their analytics offerings
Negative cash flow impacting operational sustainability
Low liquidity due to current ratio of 0.37
moderate - The company's performance is somewhat linked to healthcare spending, which can be influenced by economic cycles.
The company is less sensitive to interest rates as it primarily relies on equity financing and has a low debt level. However, higher rates could impact healthcare spending.
minimal - The company has low debt levels, reducing its exposure to credit conditions.
growth - Investors looking for innovative healthcare solutions with potential for high returns.
high - The company has experienced significant stock price fluctuations, evidenced by a 66.7% decline over the past year.